Atherosclerotic cardiovascular disease (ASCVD) is one of the major causes of death all over
the world. Atherosclerosis is developed by atherogenic lipoproteins and inflammation. Thus …

Dyslipidemia is an important etiologic factor in the development of cardiovascular disease
(CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as …

Atherosclerosis ranks first among cardiovascular system diseases. It is the “disease of the
century”, and more than 50% of people with circulatory pathology die of it. The clinical …

Dyslipidemia is a condition characterized by abnormal levels of one or more plasma lipids or
lipoproteins. It is a major cause of cardiovascular diseases (CVDs) around the world …

Dyslipidemias or dyslipoproteinemias are quantitative changes in total cholesterol
concentration, respective fractions, or triglycerides in the plasma. Evidence supported that …

Dyslipidaemia poses a significant challenge in the paediatric population, mostly due to the
fact that serum lipid abnormalities in children are often missed. It has been shown that the …

During the last 50 years, it has become evident that atherosclerosis originates in childhood.
Although cardiovascular disease (CVD) events are rare in children, autopsy data and …

In adults, dyslipidemia is an established risk factor for atherosclerotic cardiovascular disease
(ASCVD), and correcting dyslipidemia reduces the risk of ASCVD. Dyslipidemia often begins …

Atherosclerosis begins in youth and is directly linked with the presence and severity of
cardiovascular risk factors, including dyslipidemia. Thus, the timely identification and …

Background/Aims: Cardiovascular disease is the most prominent cause of mortality
worldwide. A key risk factor for atherosclerotic cardiovascular disease is the presence of …